Centervue

CenterVue S.p.A. was established in 2008 in Padua. The US subsidiary was opened in 2012.

Today, CenterVue is part of the Revenio Group. Revenio is a leading global player in eye diagnostics solutions and ophthalmic products, providing state-of-the-art technology to enable efficient diagnosis of eye diseases. Revenio's eye-related products include CenterVue imaging products for the diagnosis and monitoring of eye conditions, as well as Icare tonometers for measuring intraocular pressure (IOP).

Revenio focuses on high-technological diagnostic systems for early detection and management of sight-threatening pathologies such as glaucoma, diabetic retinopathy, and macular degeneration.

The imaging products designed and manufactured by CenterVue are highly automated, internet-connected medical devices used for diagnosing and managing ocular pathologies, including those leading causes of blindness such as diabetic retinopathy, macular degenerations, and glaucoma. Icare is the globally leading handheld tonometry brand for glaucoma diagnosis and management.

Revenio sells its products worldwide in almost 100 countries and holds several international patents and patent families. The company's installed base includes more than 7,000 imaging devices and over 80,000 tonometers globally. Revenio invests approximately 10% of its annual revenue in research and development.

The management and core team of Revenio Group possess extensive expertise in the development, marketing, and sales of ophthalmic devices.